z-logo
open-access-imgOpen Access
Modulation of mesenteric collecting lymphatic contractions by σ1-receptor activation and nitric oxide production
Author(s) -
Andrea N. Trujillo,
Christopher Katnik,
Javier Cuevas,
Byeong Jake,
Thomas E. TaylorClark,
Jerome W. Breslin
Publication year - 2017
Publication title -
ajp heart and circulatory physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.524
H-Index - 197
eISSN - 1522-1539
pISSN - 0363-6135
DOI - 10.1152/ajpheart.00702.2016
Subject(s) - nitric oxide , lymphatic system , modulation (music) , chemistry , receptor , microbiology and biotechnology , production (economics) , biophysics , medicine , cardiology , biochemistry , biology , pathology , physics , acoustics , macroeconomics , economics
Recently, it has been reported that a σ-receptor antagonist could reduce inflammation-induced edema. Lymphatic vessels play an essential role in removing excess interstitial fluid. We tested the hypothesis that activation of σ-receptors would reduce or weaken collecting lymphatic contractions. We used isolated, cannulated rat mesenteric collecting lymphatic vessels to study contractions in response to the σ-receptor agonist afobazole in the absence and presence of different σ-receptor antagonists. We used RT-PCR and Western blot analysis to investigate whether these vessels express the σ 1 -receptor and immunofluorescence confocal microscopy to examine localization of the σ 1 -receptor in the collecting lymphatic wall. Using N-nitro-l-arginine methyl ester (l-NAME) pretreatment before afobazole in isolated lymphatics, we tested the role of nitric oxide (NO) signaling. Finally, we used 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate fluorescence as an indicator to test whether afobazole increases NO release in cultured lymphatic endothelial cells. Our results show that afobazole (50–150 µM) elevated end-systolic diameter and generally reduced pump efficiency and that this response could be partially blocked by the σ 1 -receptor antagonists BD 1047 and BD 1063 but not by the σ 2 -receptor antagonist SM-21. σ 1 -Receptor mRNA and protein were detected in lysates from isolated rat mesenteric collecting lymphatics. Confocal images with anti-σ 1 -receptor antibody labeling suggested localization in the lymphatic endothelium. Blockade of NO synthases with l-NAME inhibited the effects of afobazole. Finally, afobazole elicited increases in NO production from cultured lymphatic endothelial cells. Our findings suggest that the σ 1 -receptor limits collecting lymphatic pumping through a NO-dependent mechanism. NEW & NOTEWORTHY Relatively little is known about the mechanisms that govern contractions of lymphatic vessels. σ 1 -Receptor activation has been shown to reduce the fractional pump flow of isolated rat mesenteric collecting lymphatics. The σ 1 -receptor was localized mainly in the endothelium, and blockade of nitric oxide synthase inhibited the effects of afobazole.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom